Source comparison
CJC-1295 Anti-Aging Complete Guide 2026: Comparison to Alternative GH Protocols
| Protocol | Mechanism | Administration Frequency | IGF-1 Elevation | Pulsatility Preservation | Typical Cost (12 Weeks) | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 with DAC | GHRH receptor agonist. Amplifies endogenous pulses | Twice weekly (subcutaneo
This comparison does not assign a generated winner or score.
- | Protocol | Mechanism | Administration Frequency | IGF-1 Elevation | Pulsatility Preservation | Typical Cost (12 Weeks) | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 with DAC | GHRH receptor agonist. Amplifies endogenous pulses | Twice weekly (subcutaneous) | 15–60% above baseline | Fully preserved. Enhances natural rhythm | Moderate | Best long-term option for natural GH enhancement without receptor downregulation || Exogenous HGH | Direct GH replacement. Bypasses pituitary | Daily (subcutaneous) | 200–400% above baseline (supraphysiological) | Completely suppressed | Very high | Produces rapid results but suppresses natural production and carries higher side effect risk || Sermorelin (no DAC) | GHRH receptor agonist. Short half-life | 1–2 times daily | 10–30% above baseline | Preserved but requires frequent dosing | Low to moderate | Effective but inconvenient. Half-life under 30 minutes requires multiple daily injections || MK-677 (Ibutamoren) | Ghrelin mimetic. Stimulates GH